Cargando...
Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the outcome of patients who...
Gardado en:
| Publicado en: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7244104/ https://ncbi.nlm.nih.gov/pubmed/32442193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233212 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|